Progenics Pharmaceuticals Inc (PGNX.OQ)

PGNX.OQ on NASDAQ Stock Exchange Global Select Market

5.50USD
22 May 2015
Change (% chg)

$-0.04 (-0.72%)
Prev Close
$5.54
Open
$5.56
Day's High
$5.63
Day's Low
$5.45
Volume
91,811
Avg. Vol
222,615
52-wk High
$7.83
52-wk Low
$3.32

PGNX.OQ

Chart for PGNX.OQ

About

Progenics Pharmaceuticals, Inc. is a medicine developing company. The Company is engaged in developing medicines for oncology. Its focus for Progenics is targeted therapeutics and imaging agents. The Company’s clinical development efforts center on late-stage oncology assets. Its principal clinical-stage product candidates in... (more)

Overall

Beta: 1.57
Market Cap(Mil.): $383.05
Shares Outstanding(Mil.): 69.64
Dividend: --
Yield (%): --

Financials

  PGNX.OQ Industry Sector
P/E (TTM): 85.84 37.22 39.17
EPS (TTM): 0.06 -- --
ROI: 2.46 16.24 15.58
ROE: 3.11 16.99 16.57
Search Stocks

Earnings vs. Estimates

Search Stocks